You are here
Home > Blog > Uncategorized > Emerging Threats – Avian Influenza and Human Metapneumovirus (HMPV)

Emerging Threats – Avian Influenza and Human Metapneumovirus (HMPV)

Emerging Threats – Avian Influenza & Human Metapneumovirus (HMPV)

Avian Influenza

 

Avian Influenza

Avian influenza, commonly known as bird flu, poses a significant risk to both animal and human health. The virus primarily spreads among birds, but certain strains, such as H5N1 and H7N9, have shown the ability to infect humans. These strains are highly pathogenic, meaning they can cause severe disease and high mortality rates in birds, and they have the potential to cause serious illness in humans as well. The risk of avian influenza to the general public remains low, but those who work closely with birds, such as poultry farmers and veterinarians, are at a higher risk of exposure.

The H5N1 strain, also known as the “bird flu virus,” has been circulating in wild birds and poultry for several years. It is known for its high pathogenicity and has caused numerous outbreaks in poultry farms across the globe. Human infections with H5N1 are rare but can be severe, leading to respiratory issues, organ failure, and even death. The virus is transmitted to humans through direct contact with infected birds or their secretions, such as saliva, mucous, or feces. Although human-to-human transmission of H5N1 is uncommon, it remains a concern due to the potential for the virus to mutate and become more easily transmissible among humans.

 


H5N1 and H7N9

[Link]

Please like and subscribe if you enjoyed this video 🙂  Our new channel is ~ two-months old and subscribing helps ensure you never miss a video.
Just click on the small globe that appears in the lower right corner.

 


Youtube

 

Human Metapneumovirus (HMPV)

Human metapneumovirus (HMPV) is causing a significant pneumonia outbreak in China, primarily affecting children and the elderly. Hospitals are overwhelmed, and healthcare officials are concerned about the rapid spread. HMPV, identified in the Netherlands in 2001, is now a global health issue. It peaks seasonally, especially in spring, with transmission influenced by environmental conditions. Severe cases often require hospitalization and intensive care. Current measures include isolation protocols and supportive care, but no FDA-approved antiviral therapy exists. Understanding transmission patterns and demographic impacts is crucial for managing this outbreak and preventing future ones.
[Link]


 

About Author

Similar Articles

Leave a Reply


thpxl